interferon alpha ultra (PBL)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterferon alpha ultra (PBL)
Drug Alias NameIFN alpha SuRe-PD (PBL)interferon alpha SuRe-PD (PBL)interferon alpha SuRe-PD (PBL)IFN alpha ultra (PBL)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsCryoglobulinemiaPrecancerous ConditionsNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorld
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPBL Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPBL Therapeutics
Active IndicationsN/A
Inactive IndicationsCryoglobulinemiaPrecancerous ConditionsNeoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A